Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells

International Journal of Gynecological Cancer

Volumn 22, Issue 7, 2012, Pages 1130-1137

  Adurthi, Sreenivas ^a   Mukherjee, Geetashree ^a   Krishnamurthy, H ^b   Sudhir, Krishna ^b   Bafna, Uttamchand D ^a   Umadevi, Kswamy ^a   Jayshree, Rudrapatna Subramanyam ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

^b TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

Cervical cancer; FOXP3; Regulatory T cells; TH1 TH2 effectors; Tumor infiltrating lymphocytes

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; CYTOKINE;

CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CELL SELECTION; CELL SEPARATION; CELLULAR SECRETION; CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE SEVERITY; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; TISSUE SECTION; TUMOR MICROENVIRONMENT; UTERINE CERVIX CARCINOMA; ARTICLE; CANCER STAGING; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR ASSOCIATED LEUKOCYTE; UTERINE CERVIX TUMOR;

CARCINOMA, SQUAMOUS CELL; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; NEOPLASM STAGING; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; UTERINE CERVICAL NEOPLASMS;

EID: 84869443740     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318262aa53     Document Type: Conference Paper

References (32)

1. WHO. Initiative for Vaccine Research (IVR). Human papillomavirus. 2007 http://www.who.int/vaccine-research/diseases/viral-cancers/en/index3.html. Accessed April 1, 2009.
2. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Institut Català d'Oncologia Avda. Gran Via, s/n Km 2.7 08907 L'Hospitalet de Llobregat (Barcelona, Spain) Human Papillomavirus and Related Cancers in India. Summary Report 2009. http://www.who.int/hpvcentre/en/.Accessed September 15, 2010.
3. Wheeler CM. Advances in primary and secondary interventions for cervical cancer: human papillomavirus prophylactic vaccines and testing. Nat Clin Pract Oncol. 2007;4:224-235.
4. Frazer IH, Quinn M, Nicklin JL, et al. Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia. Vaccine. 2004;23:172-181.
5. Sakaguchi S, Miyara M, Costantino CM, et al. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10:490-500.
6. Evans EM, Man S, Evans AS, et al. Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes. Cancer Res. 1997;57:2943-2950.
7. + tumor-infiltrating lymphocytes is 12associated with the absence of lymph node metastases in patients with large early stage cervical cancer. Cancer Res. 2007;67:354-361.
8. Höhn H, Pilch H, Günzel S, et al. Human papillomavirus type 33 E7 peptides presented by HLA-DR*0402 to tumor-infiltrating T cells in cervical cancer. J Virol. 2000;74:6632-6636.
9. + regulatory T cells specific for human papillomavirus antigens. Proc Natl Acad Sci U S A. 2007;104:12087-12092.
10. de Vos van Steenwijk PJ, Heusinkveld M, Ramwadhdoebe TH, et al. An unexpectedly large polyclonal repertoire of HPV-specific T cells is poised for action in patients with cervical cancer. Cancer Res. 2010;70:2707-2717.
11. Heusinkveld M, Welters MJ, van Poelgeest MI, et al. The detection of circulating human papillomavirus-specific T cells is associated with improved survival of patients with deeply infiltrating tumors. Int J Cancer. 2011;128:379-389.
12. Hathcock KS. T cell enrichment by nonadherence to nylon. Curr Protoc Immunol. 2001; chapter 3: unit 3.2.
13. + T cells. Clin Immunol. 2005;115:10-18.
14. Adurthi S, Krishna S, Mukherjee G, et al. Regulatory T cells in a spectrum of HPV-induced cervical lesions: cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma. Am J Reprod Immunol. 2008;60:55-65.
15. Kobayashi A, Greenblatt RM, Anastos K, et al. Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Res. 2004;64:6766-6774.
16. Murai M, Krause P, Cheroutre H, et al. Regulatory T-cell stability and plasticity in mucosal and systemic immune systems. Mucosal Immunol. 2010;3:443-449.
17. Piersma SJ, Welters MJ, van der Burg SH. Tumor-specific regulatory T cells in cancer patients. Hum Immunol. 2008;69:241-249.
18. + T-cell infiltration and survival of patients with cervical carcinoma. Clin Cancer Res. 2009;15:6341-6347.
19. + T cells expressing the FoxP3 transcription factor. Immunity. 2009;30:899-911.
20. + CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers. J Immunol. 2007;179:4323-4334.
21. + regulatory T cells specific for human papillomavirus antigens. Proc Natl Acad Sci U S A. 2007;104:12087-12092.
22. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med. 2004;10:801-805.
23. Kobayashi A, Weinberg V, Darragh T, et al. Evolving immunosuppressive microenvironment during human cervical carcinogenesis. Mucosal Immunol. 2008;1:412-420.
24. van Driel WJ, Kievit-Tyson P, van den Broek LC, et al. Presence of an eosinophilic infiltrate in cervical squamous carcinoma results from a type 2 immune response. Gynecol Oncol. 1999;74:188-195.
25. H2-mediated anti-tumor immunity: friend or foe? Tissue Antigens. 2007;70:1-11
26. + T-cell-mediated anti-tumor immunity can be uncoupled from autoimmunity via the STAT4/STAT6 signaling axis. Eur J Immunol. 2009;39:1252-1259.
27. + T-cell immunity against early antigens E2 and E6. Cancer Res. 2004;64:5449-5455.
28. Welters MJ, Kenter GG, de Vos van Steenwijk PJ, et al. Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses. Proc Natl Acad Sci USA. 2010;107:11895-11899.
29. Kosmidis M, Dziunycz P, Suárez-Fariñas M, et al. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients. J Immunother. 2010;33:538-546.
30. McGuirk P, Mills KH. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol. 2002;23:450-455.
31. Sheu BC, Lin RH, Lien HC, et al. Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol. 2001;167:2972-2978.
32. Jayshree RS, Sreenivas A, Tessy M, et al. Cell intrinsic & extrinsic factors in cervical carcinogenesis. Indian J Med Res. 2009;130:286-295.